Orbis Allan Gray Ltd
Institutional investor · Portfolio as of Q1 2025
Top Holdings78 positions
QXO INC COM NEW | 109.4M | $1.5B | 8.5% | — | — | — | Unchanged 0 |
CORPAY INC COM SHS | 3.7M | $1.3B | 7.4% | $308.54 | +13.02% | 5 qtrssince 2024-Q1 | Decreased 0 |
ANTHEM INC | 2.8M | $1.2B | 7.1% | $359.78 | +17.38% | 25 qtrssince 2019-Q1 | Increased 79 |
KINDER MORGAN INC DEL | 22M | $626.6M | 3.6% | $19.08 | +40.74% | 15 qtrssince 2021-Q3 | Decreased 0 |
Interactive Brokers Group Inc | 3.5M | $578.5M | 3.3% | $17.99 | +128.51% | 14 qtrssince 2021-Q4 | Decreased 0 |
RXO INC COMMON STOCK | 30.2M | $577.4M | 3.3% | $21.73 | -13.20% | 10 qtrssince 2022-Q4 | Decreased 0 |
GXO LOGISTICS INCORPORATED COMMON STOCK | 13.5M | $526.5M | 3.0% | $58.55 | -32.85% | 15 qtrssince 2021-Q3 | Increased 61 |
BRITISH AMERN TOB PLC | 12M | $497.3M | 2.8% | $27.84 | +36.17% | 25 qtrssince 2019-Q1 | Increased 64 |
SHELL PLC SPON ADS | 6.5M | $473.1M | 2.7% | $50.11 | +38.12% | 13 qtrssince 2022-Q1 | Decreased 0 |
SMURFIT WESTROCK PLC SHS | 10.1M | $455.7M | 2.6% | $47.38 | -9.39% | 3 qtrssince 2024-Q3 | Increased 81 |
ALNYLAM PHARMACEUTICALS INC | 1.6M | $441.5M | 2.5% | $255.43 | +5.71% | 4 qtrssince 2024-Q2 | Increased 59 |
RENAISSANCERE HLDGS LTD | 1.7M | $419.6M | 2.4% | $200.85 | +20.29% | 10 qtrssince 2022-Q4 | Decreased 0 |
NETEASE INC | 3.7M | $377.2M | 2.2% | $74.34 | +33.88% | 25 qtrssince 2019-Q1 | Decreased 0 |
MICROCHIP TECHNOLOGY INC. | 7.6M | $369.6M | 2.1% | — | — | — | New 80 |
DISNEY WALT CO | 3.6M | $354.2M | 2.0% | $87.08 | +11.25% | 7 qtrssince 2023-Q3 | Increased 64 |
Steris PLC | 1.5M | $350M | 2.0% | $221.34 | 0.00% | 1 qtr | New 80 |
UnitedHealth Group Inc. | 665,142 | $348.4M | 2.0% | $410.28 | +22.69% | 25 qtrssince 2019-Q1 | Decreased 0 |
AES CORP | 27.5M | $341.8M | 2.0% | $18.13 | -36.76% | 19 qtrssince 2020-Q3 | Increased 59 |
YANDEX N V | 15.7M | $331.5M | 1.9% | $26.92 | -17.12% | 18 qtrssince 2020-Q4 | Decreased 0 |
Motorola Solutions Inc | 736,093 | $322.3M | 1.8% | $183.71 | +134.43% | 20 qtrssince 2020-Q2 | Increased 49 |
Orbis Allan Gray Ltd manages $17.5B across 78 positions as of Q1 2025. Top holdings: QXO (8.5%), CPAY (7.4%), ELV (7.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Active quarter - 7 new positions, 13 exits, 34 increased. Top move: SW (INCREASED, conviction 81). Portfolio: $17.5B across 78 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR